NCT04458935View on ClinicalTrials.gov

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

Active, not recruitingOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Retinal HemangioblastomaVon Hippel-Lindau Disease

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH